Eurand, Anesta Sue Anchen Over Generic Amrix

Law360, New York (April 1, 2011, 7:15 PM EDT) -- Eurand Inc. and Anesta AG slapped Anchen Inc. with a patent infringement suit in Delaware on Wednesday over the generic-drug maker's efforts to market a version of the muscle relaxer Amrix.

In a complaint filed in the U.S. District Court for the District of Delaware, Eurand and Anesta claim the submission of an abbreviated new drug application for generic Amrix by Irvine, Calif.-based Anchen and a closely related company, Anchen Pharmaceuticals Inc., infringes two patents. Both Anchen companies are named as defendants in the suit....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.